Regenerative Medical Technology Group Inc. — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7be61e67-c0c9-4ccc-a7f5-e9535cafed50/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-7.8M | 2025-01-01 – 2025-12-31 | evidence 0001213900-26-056841 |
| FY 2024 | $-5.6M | 2024-01-01 – 2024-12-31 | evidence 0001213900-25-032016 |
| FY 2023 | $-9.8M | 2023-01-01 – 2023-12-31 | evidence 0001213900-24-032991 |
| FY 2022 | $-5.5M | 2022-01-01 – 2022-12-31 | evidence 0001213900-23-029942 |
| FY 2021 | $-12.9M | 2021-01-01 – 2021-12-31 | evidence 0001213900-22-024049 |
| FY 2020 | $-5.9M | 2020-01-01 – 2020-12-31 | evidence 0001213900-21-021343 |
| FY 2019 | $-2.5M | 2019-01-01 – 2019-12-31 | evidence 0001213900-20-041866 |
| FY 2018 | $-2.1M | 2018-01-01 – 2018-12-31 | evidence 0001213900-19-006566 |
| FY 2017 | $-377.0k | 2017-01-01 – 2017-12-31 | evidence 0001213900-19-006566 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Regenerative Medical Technology Group Inc. — all facts · Revenue · Operating Income